Portal Login:
  • Clients
  • Providers
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
    Portal Login:
  • Clients
  • Providers
  • About MCN
  • Careers
  • MCNTalk
  • Contact Us

MCN | Medical Consultants Network

The Power of a Second Look

  • Services
    • Independent Medical Examinations
    • Medical Peer Reviews
    • Bill Review Services
    • Utilization Reviews
  • Expertise
    • Short and Long-Term Disability
    • Workers’ Compensation
    • Auto/PIP/Casualty/Liability
    • Independent Review Organization Services
  • For Clients
  • For Providers
  • Your Exam
    • About Your Exam
    • About Your External Review
    • Contact & Scheduling
  • Schedule Now
  • About MCN
  • MCNTalk
  • Careers
  • Contact Us

MCNTalk
News, Insights & Opinions

Home / MCNTalk / Little Pricey Pill

March 31, 2010

Little Pricey Pill

Arrgh. This article from April 12, 2010 Forbes ought to raise the ire of many a reader who needs a simple example of how our health care system is sick! You might even want to swallow a couple of the pills described, as they are used to treat ‘heartburn’.

It outlines what happens in a system when one is spending other people’s money. One is willing to have other people pay a lot more for something perhaps marginally more effective than a drug available over the counter ($165 per month vs. less than $20.00). Some companies and government payers wisely stopped paying altogether, saving millions with the stroke of a pen, and likely having zero impact on the health of their insured.

In fact, as a physician and an occasional patient, I find myself asking a question not raised in the article: How many of these pills ought to be taken at any price, rather than living with the occasional discomfort, or altering one’s diet or other lifestyle changes. A focus on cost of care ought to be combined with attention to need for care.

A side issue in the article is that mention is made of a panel to oversee effectiveness of treatments to determine Medicare disbursements being eliminated due to lobbying. The article I posted yesterday appears to reference a similar panel being in place. If any reader knows the distinction between these two, please comment.

47.608945-122.332015

Share this:

  • Twitter
  • Email
  • More
  • Facebook
  • Reddit
  • Print

Tagged: Clinical Issues, Health Policy Leave a Comment

Previous Post
Next Post

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • The Quality Divide: What Makes a Quality IME Physician?
  • The Quality Divide: Is Your Vendor Driving IME Excellence?
  • The Quality Divide: When and How to Request an IME?
  • April Clinic Calendars Are Available
  • MCN’s Client Portal Login Page is Changing

Archives

Footer


  • Twitter
  • LinkedIn

Quick Links

  • Services
  • Expertise
  • About MCN
  • Careers

Division Headquarters

MCN
1200 5th Ave., Ste. 650
Seattle, WA 98101

See all offices

Email Us

General Inquiries: info@mcn.com
Sales & Marketing: marketing@mcn.com

Call Us

206.343.6100
800.248.6269

© Copyright 2023 Mitchell International, Inc. All Rights Reserved.

  • Privacy Policy
  • Sitemap